Literature DB >> 14598046

Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.

J Bayry1, M Thirion, N Misra, N Thorenoor, S Delignat, S Lacroix-Desmazes, B Bellon, S Kaveri, M D Kazatchkine.   

Abstract

Intravenous immunoglobulins (IVIg) exert a broad range of immunoregulatory functions that provide a basis for the beneficial effects of IVIg in autoimmune and systemic inflammatory disorders. This review focuses on the effects f IVIg on humoral and cellular immunity that may be of relevance for the treatment of inflammatory neurological diseases.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14598046     DOI： 10.1007/s10072-003-0081-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  21 in total

Review 1.  Toward molecular targeting with specific intravenous immunoglobulin preparation.

Authors:  Miri Blank; Israel Nur; Orgad Toub; Anabel Maor; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Intravenous immunoglobulin and fibrosis.

Authors:  Vered Molina; Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  New concepts in antibody-mediated immunity.

Authors:  Arturo Casadevall; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

4.  sHLA-I Contamination, a novel mechanism to explain ex vivo/in vitro modulation of IL-10 synthesis and release in CD8(+) T lymphocytes and in neutrophils following intravenous immunoglobulin infusion.

Authors:  Massimo Ghio; Paola Contini; Maurizio Setti; Gianluca Ubezio; Clemente Mazzei; Gino Tripodi
Journal:  J Clin Immunol       Date:  2010-02-02       Impact factor: 8.317

5.  Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products.

Authors:  Christine W Bruggeman; Sietse Q Nagelkerke; Wendy Lau; Cedric Manlhiot; Masja de Haas; Robin van Bruggen; Brian W McCrindle; Rae S M Yeung; Taco W Kuijpers
Journal:  Blood Adv       Date:  2020-07-28

Review 6.  The advantage of specific intravenous immunoglobulin (sIVIG) on regular IVIG: experience of the last decade.

Authors:  Nina Svetlicky; Oscar-Danilo Ortega-Hernandez; Luc Mouthon; Loic Guillevin; Hans-Jurgen Thiesen; Arie Altman; Martine Szyper Kravitz; Miri Blank; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2012-12-11       Impact factor: 8.317

7.  Immunoglobulins in adult sepsis and septic shock.

Authors:  Susanne Toussaint; Herwig Gerlach
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

8.  Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection.

Authors:  Ennio Polilli; Giustino Parruti; Francesca D'Arcangelo; Elisa Tracanna; Luigi Clerico; Vincenzo Savini; Francesco D'Antonio; Maurizio Rosati; Lamberto Manzoli; Domenico D'Antonio; Giovanni Nigro
Journal:  Clin Vaccine Immunol       Date:  2012-10-24

9.  Effects of scleroderma antibodies and pooled human immunoglobulin on anal sphincter and colonic smooth muscle function.

Authors:  Jagmohan Singh; Sidney Cohen; Vaibhav Mehendiratta; Fabian Mendoza; Sergio A Jimenez; Anthony J Dimarino; Satish Rattan
Journal:  Gastroenterology       Date:  2012-08-01       Impact factor: 22.682

10.  Reduction of the HIV-1 reservoir in resting CD4+ T-lymphocytes by high dosage intravenous immunoglobulin treatment: a proof-of-concept study.

Authors:  Annica Lindkvist; Arvid Edén; Melissa M Norström; Veronica D Gonzalez; Staffan Nilsson; Bo Svennerholm; Annika C Karlsson; Johan K Sandberg; Anders Sönnerborg; Magnus Gisslén
Journal:  AIDS Res Ther       Date:  2009-07-01       Impact factor: 2.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.